Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127892942 | 12789294 | 2 | F | 20160826 | 20160920 | 20160928 | 20160930 | EXP | IT-MINISAL02-374645 | IT-TEVA-694725ACC | TEVA | 45.63 | YR | F | Y | 48.00000 | KG | 20160930 | PH | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127892942 | 12789294 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | 1480 MG CYCLICAL | U | 0 | 1480 | MG | SOLUTION FOR INFUSION | ||||||
| 127892942 | 12789294 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | 185 MG CYCLICAL | U | 0 | 185 | MG | SOLUTION FOR INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127892942 | 12789294 | 1 | Pancreatic carcinoma |
| 127892942 | 12789294 | 2 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127892942 | 12789294 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127892942 | 12789294 | Enteritis | |
| 127892942 | 12789294 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127892942 | 12789294 | 1 | 20160601 | 0 | ||
| 127892942 | 12789294 | 2 | 20160601 | 0 |